2BB score and signals
Karyopharm Therapeutics Inc.’s current 2BB score is 34 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 45 | Moderate |
| Momentum | 36 | Weakening |
| Financial strength | 7 | Very Weak |
| Quality | 97 | Very Strong |
| Risk | 94 | Very High |
Company facts
| Headquarters | Newton, Massachusetts, United States |
| Founded | 2008 |
| Employees | 228 |
| 52-week range | $0.32 – $10.99 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-10 | — | -0.867 | — | $35.00M |
| 2026-10-29 | — | -0.9649 | — | $34.22M |
| 2026-08-13 | — | -1.3022 | — | $32.83M |
| 2026-05-14 | -1.24 | -1.4571 | $35.07M | $32.03M |
Related companies
2BBBullish & Bearish